PRIMACOR Trademark

Trademark Overview

On Friday, October 15, 2021, a trademark application was filed for PRIMACOR with the United States Patent and Trademark Office. The USPTO has given the PRIMACOR trademark a serial number of 97076386. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, April 30, 2024. This trademark is owned by Validus Pharmaceuticals LLC. The PRIMACOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation, namely, inotropic/vasodilating agent for treating congestive heart failure
primacor

General Information

Serial Number97076386
Word MarkPRIMACOR
Filing DateFriday, October 15, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, April 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 29, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparation, namely, inotropic/vasodilating agent for treating congestive heart failure

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 4, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameValidus Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054
Party NameValidus Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Tuesday, October 19, 2021NEW APPLICATION ENTERED
Thursday, November 4, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 3, 2022ASSIGNED TO EXAMINER
Monday, February 7, 2022NON-FINAL ACTION WRITTEN
Monday, February 7, 2022NON-FINAL ACTION E-MAILED
Monday, February 7, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 18, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, February 18, 2022EXAMINERS AMENDMENT E-MAILED
Friday, February 18, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 18, 2022EXAMINER'S AMENDMENT ENTERED
Friday, February 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 29, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 29, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 24, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, October 28, 2022SOU TEAS EXTENSION RECEIVED
Friday, October 28, 2022SOU EXTENSION 1 FILED
Friday, October 28, 2022SOU EXTENSION 1 GRANTED
Tuesday, November 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 4, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 4, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 4, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 2, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 2, 2023SOU EXTENSION 2 FILED
Tuesday, May 2, 2023SOU EXTENSION 2 GRANTED
Thursday, May 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 13, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 13, 2023SOU EXTENSION 3 FILED
Monday, November 13, 2023SOU EXTENSION 3 GRANTED
Wednesday, November 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 30, 2024SOU EXTENSION 4 GRANTED
Tuesday, April 30, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 30, 2024SOU EXTENSION 4 FILED
Wednesday, May 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 22, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

primacor treating congestive heart failure agent vasodilating preparation namely inotropic pharmaceutical